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The 1978 Annuai Report of the International Joint Commission's Committee
on the Assessment of Human Health Effects of Great Lakes Water Quaiity was
prepared both for the Water Quaiity Board and for the Science Advisory Board.
Highiights from the activities of the Committee, from its inaugurai
meeting, eariy in 1978 to the present, are reported here.
 
  
 
 4
>
(
A
)
o
0
T
I
M
E
V
I
E
[
E
U
W
U
E
W
H
PREFACE
INTRODUCTION
- Terms of Reference
HE
AL
TH
HA
ZA
RD
EV
AL
UA
TI
ON
TOXICITY EVALUATION
ES
TI
MA
TE
S
OF
HU
MA
N
EX
PO
SU
RE
FR
OM
EN
VI
RO
NM
EN
TA
L
DA
TA
IN
TE
RA
CT
IO
NS
IN
TO
XI
CO
LO
GY
:
AN
OV
ER
VI
EW
TRANSFORMATION
—
Mi
re
x
an
d
It
s
De
gr
ad
at
io
n
Pr
od
uc
ts
— Lead
RECOMMENDATIONS
MEMBERSHIP
IJ
C
Co
mm
it
te
e
on
th
e
As
se
ss
me
nt
of
Hu
ma
n
He
aI
th
Ef
fe
ct
s
15
19
27
28
31
33
 
 
 UMWEWWWWM
One of the most important recommendations contained in the Sixth Annual
Great Lakes Water Quality Report of the International Joint Commission (1978)
has urged that the Governments of the United States and Canada “collaborate
and develop a program which establishes a running inventory of toxic chemicals
used, manufactured or imported into the Great Lakes Basin" and "evaluate their
risk to human health and the environment.” As a result of its continuing and
growing concern over the potential human health hazards of contaminants which
bioaccumulate in fish, a special committee on the Assessment of Human Health
Effects of Great Lakes Water Quality was formed in early 1978.
TERMS OF REFERENCE
In considering its mandate, the committee proposed and agreed to take the
following under its purview:
1. Assess the risk to health posed by contaminants in the Great Lakes
ecosystem.
2.
Rev
iew
act
ion
lev
els
and
gui
del
ine
s f
or
sel
ect
ed
sub
sta
nce
s.
3. Provide to the International Joint Commission through its Boards,
interpretation and consultation on health matters.
4.
Main
tain
awar
enes
s of
curr
ent
adva
nces
and
know
ledg
e as
they
rela
te t
o
human health aspects of the ecosystem.
The
resu
lt o
f th
e in
augu
ral
meet
ing
of t
his
comm
itte
e wa
s a
deci
sion
to
rev
iew
the
197
5 W
ate
r Q
ual
ity
Boa
rd'
s A
ppe
ndi
x E
, "
Sta
tus
Rep
ort
on
the
Per
sis
ten
t T
oxi
c S
ubs
tan
ces
in
the
Lak
e O
nta
rio
Bas
in.
"
The
com
pou
nds
selected for study initially were lead and mirex.
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ed
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e
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ma
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ag
ra
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lo
w:
A
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EXPOSURE
— PATTERN (TIME)
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MA
NA
ET
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.
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CY
.
ET
C.
C
h
a
p
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e
r
2
o
n
T
o
x
i
c
i
t
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E
v
a
l
u
a
t
i
o
n
in
t
h
i
s
r
e
p
o
r
t
i
d
e
n
t
i
f
i
e
s
t
h
e
c
a
t
e
g
o
r
i
e
s
u
s
e
d
to
s
e
l
e
c
t
c
h
e
m
i
c
a
l
s
p
o
s
i
n
g
h
u
m
a
n
h
e
a
l
t
h
h
a
z
a
r
d
s
an
d
p
r
o
v
i
d
e
s
an
a
p
p
r
o
p
r
i
a
t
e
"
s
c
o
r
i
n
g
"
s
y
s
t
e
m
.
A
l
s
o
,
C
h
a
p
t
e
r
3
o
n
H
u
m
a
n
E
x
p
o
s
u
r
e
e
x
p
l
o
r
e
s
t
h
e
r
o
u
t
e
s
f
o
r
e
n
v
i
r
o
n
m
e
n
t
a
l
c
o
n
t
a
m
i
n
a
t
i
o
n
by
t
h
e
s
e
c
h
e
m
i
c
a
l
s
.
 
 
  
ZTOXICITY EVALUATION
The
com
mit
tee
,
at
its
Oct
obe
r 1
978
mee
tin
g,
dis
cus
sed
the
pro
ble
m o
f
est
abl
ish
ing
cri
ter
ia
for
rat
ing
the
haz
ard
s p
res
ent
ed
by
the
400
che
mic
als
rec
ent
ly
ide
nti
fie
d i
n t
he
Gre
at
Lak
es
by
the
Gre
at
Lak
es
Wat
er
Qua
lit
y B
oar
d;
see
Gre
at
Lak
es
Wat
er
Qua
lit
y B
oar
d
— A
ppe
ndi
x
E,
Sta
tus
Rep
ort
on
Org
ani
c
and
Hea
vy
Met
al
Con
tam
ina
nts
in
the
Lak
es
Eri
e,
Mic
hig
an,
Hur
on
and
Sup
eri
or
Bas
in,
by
D.
Kon
ase
wic
h,
N.
Tra
ver
sy,
H.
Zar
, J
uly
197
8,
Win
dso
r,
Ont
ari
o.
The
197
8
Mic
hig
an
Cri
tic
al
Mat
eri
als
Pub
lic
ati
on,
pub
lis
hed
by
the
Off
ice
of
Tox
ic
Mat
eri
als
Con
tro
l,
Mic
hig
an
Dep
art
men
t
of
Nat
ura
l
Res
our
ces
,
for
med
th
e
ba
si
s
fo
r
co
mm
it
te
e
re
vi
ew
and
di
sc
us
si
on
.
Th
e
ch
em
ic
al
s
in
th
e
Mi
ch
ig
an
doc
ume
nt
inc
lud
e
tho
se
wit
h
wel
l
rec
ogn
ize
d
hig
h
tox
ici
ty
(e.
g.,
PCB
s,
me
rc
ur
y,
cy
an
id
e)
,
th
os
e
ob
ta
in
ed
fr
om
va
ri
ou
s
li
st
s
of
pr
io
ri
ty
ch
em
ic
al
s
dev
elo
ped
by
NIO
SH,
U.S
.
EPA
,
etc
.,
and
che
mic
als
of
spe
cif
ic
con
cer
n
to
Michigan.
Mic
hig
an'
s
rev
iew
pro
ces
s
uti
liz
es
a h
aza
rd
ass
ess
men
t
met
hod
olo
gy
whi
ch
con
sid
ers
acu
te
and
chr
oni
c
tox
ici
ty,
car
cin
oge
nic
ity
,
mut
age
nic
ity
,
te
ra
to
ge
ni
ci
ty
,
pe
rs
is
te
nc
e,
bi
oa
cc
um
ul
at
io
n
an
d
ae
st
he
ti
cs
.
Ch
em
ic
al
s
ar
e
nu
me
ri
ca
ll
y
sc
or
ed
as
to
th
ei
r
ha
za
rd
and
th
os
e
po
si
ng
a
hi
gh
en
vi
ro
nm
en
ta
l
co
nc
er
n
(i.
e.,
a
hi
gh
sco
re)
are
in
cl
ud
ed
in
th
e
Cr
it
ic
al
Ma
te
ri
al
s
Pu
bl
ic
at
io
n.
Ta
bl
e
9
-
“C
ri
ti
ca
l
Ma
te
ri
al
s
Re
gi
st
er
Ha
za
rd
As
se
ss
me
nt
Sh
ee
t,
"
is
re
pr
od
uc
ed
be
lo
w
fr
om
the
Mi
ch
ig
an
pu
bl
ic
at
io
n.
The
Hum
an
Hea
lth
Eff
ect
s
Com
mit
tee
sel
ect
ed
the
fol
low
ing
cat
ego
rie
s:
- acute toxicity;
- carcinogenicity;
- reproductive;
- heritable mutagenicity;
- neurobehavioural toxicity; and
- chronic adverse effects.
I. ACUTE TOXICITY
Criterion:
Sc
or
e
Or
al
L0
50
De
rm
al
L0
50
4
Ex
tr
em
el
y
To
xi
c
<5
mg
/k
g
<5
mg
/k
g
3
Hi
gh
ly
To
xi
c
5-
50
mg
/k
g
5—
20
0
mg
/k
g
2
Mo
de
ra
te
ly
To
xi
c
<5
0-
50
0
mg
/k
g
<2
00
—S
OO
mg
/k
g
1
Sl
ig
ht
ly
To
xi
c
<O
.5
-5
g/
kg
<O
.5
-5
g/
kg
O
Re
la
ti
ve
ly
No
n-
To
xi
c
<5
g/
kg
<5
g/
kg
* Insufficient information
 
 Table 9.
Mich
igan
 
Critic
al Ma
teria
ls Re
giste
r Haz
ard A
ssess
ment
Sheet
Cannon Ch
emical N
ame
Chemical
Abstract
Name
 
Score
I. Acute
Toxicity
Score
Category
ORAL L050
DERMAL L050
AQUATIC 96 HO
UR LDSO
mg/kg
mg/kg
mg/l
<5
<5
<1
5-50
5-200
1-10
>50-500 >200-500 >10—100
>500-5000 >500-5000 >100-1000
>5000 >5000 >1000
Insufficient
Information
[
\
M
N
v
—
‘
C
‘
k
II. Carci
nogenicit
y
Score Category
7 Human
positive hu
man suspect
on Animal positive
3 A
nimal su
spect
2
Carci
nogen
ic by
a rout
e oth
er th
an or
al or
dermal
Stron
gly p
otenti
al ca
rcino
genic
by ac
cepted
mutag
enici
ty
scree
ning
tests
or ac
cepte
d cel
l tra
nsfor
matio
n stu
dies
1
Potent
ial c
arcin
ogen
by acc
epted
mutag
encit
y scr
eenin
g
tests
or ac
cepte
d cel
l tra
nsfor
matio
n stu
dies
0 Not
carcinogenic
*
Insuf
ficie
nt In
format
ion
III.
Hered
itary
Mutag
enici
ty
Score
Cate
gory
Co
nf
ir
me
d
Susp
ect
- mu
ltic
ellu
lar
orga
nism
s
Susp
ect
- mi
cro-
orga
nism
s
Not
a he
redi
tary
muta
gen
Insuf
ficie
nt In
forma
tion
N
V
N
O
Q
‘
IV.
Terat
ogeni
city
Score
Cate
gory
Confirmed
Susp
ect
Not teratogenic
Insuff
icien
t Inf
ormat
ion
[
\
M
C
)
!
Chem
ical
Abst
ract
No.
V. Per
sistenc
e
Sco
re
 
a
r
r
o
w
—
«
o
i
Ca
te
go
ry
Very p
ersiste
nt
Per
sis
ten
t
Slowly degradable
Moder
ately
degra
dable
Readily
degradabl
e
Insufficient
Information
VI.
Bio
acc
umu
lat
ion
Score
N
M
N
H
O
‘
Bioaccu
mulatio
n
Log P
>4000
>6.00
1000-39
99
5.00-5.
99
700-999
4.50-4.99
300-699
4.00-4.
49
<300
<4.00
Insufficient
Information
VII. A
estheti
cs
Score
M
N
v
—
‘
O
Category
Fish
Taint
ing/T
ase a
nd
Odor (Threshold level
in wate
r - mg
/l)
0.0001-0.001
>0.001-0.01
>0.01-0.1
Yes
>0.1
No
Foaming,
floating
film, and/or major
colour
change
VIII. Chronic Adverse Effects
Scare
4
2
1
0
*
Cate
gory
Irreversible effects
Reversible effects
Adverse effects by route
other than oral, dermal,
or aq
uatic
No detectable adverse effects
Insufficient Information
 Rationale:
Cla
ssi
fic
ati
on
is
bas
ed
upon
gen
era
lly
acc
ept
ed
ter
min
olo
gy
fou
nd
in
the
available literature on acute toxicity.
In
rev
iew
of
the
lit
era
tur
e r
efe
ren
ced
belo
w,
dea
lin
g w
ith
the
classification of toxicants, never was less than 50 mg/kg considered
mod
era
tel
y t
oxic
.
In
EPA
's
TSC
A c
rit
eri
a f
or
acu
te
tox
ici
ty,
50
to
500
mg/
kg
is
cla
ssi
fie
d a
s "
ver
y t
oxi
c"
as
is
one
of
the
sys
tem
s d
esc
rib
ed
by
Hod
ge a
nd
Sterner (1949) and Gleason (1969).
The
cri
tic
al
lev
els
des
cri
bin
g "
hig
hly
tox
ic"
for
ora
l,
der
mal
, a
nd
aqu
ati
c L
C50
5 a
re
ada
pte
d f
rom
Bat
tel
le
Mem
ori
al
Ins
tit
ute
, N
ati
ona
l A
cad
emy
of
Sci
enc
es,
Sta
te
of
Cal
ifo
rni
a L
ist
of
Tox
ic
Sub
sta
nce
s,
Fed
era
l
Wat
er
Pol
lut
ion
Con
tro
l A
gen
cy,
Pes
tic
ide
s-T
itl
e 4
0,
Dep
art
men
t o
f T
ran
spo
rta
tio
n
Tit
le
49,
Con
sum
er
Pro
duc
t S
afe
ty
Com
mis
sio
n,
and
the
Fed
era
l
Haz
ard
ous
Sub
sta
nce
s L
abe
lin
g A
ct
Tit
le
15
cla
ssi
fic
ati
ons
,
as
wel
l
as
sys
tem
s p
res
ent
ed
by
Hod
ge
and
Ste
rne
r
(19
49)
.
Lev
els
of
"mo
der
ate
,"
"sl
igh
tly
"
and
"re
lat
ive
ly
non
tox
ic“
are
ada
pte
d f
rom
the
Nat
ion
al
Aca
dem
y o
f S
cie
nce
s,
and
Hod
ge
and
Sterner (1949).
Dat
a a
vai
lab
le
for
eac
h c
ate
gor
y f
or
eac
h t
ype
of
exp
osu
re
(i.
e.,
ora
l,
der
mal
,
aqu
ati
c)
is
sco
red
ind
epe
nde
ntl
y.
The
sco
re
ass
ign
ed
to
the
acu
te
tox
ici
ty
fac
tor
is
the
hig
hes
t
sco
re
giv
en
to
any
ind
ivi
dua
l
cat
ego
ry.
For
exa
mpl
e,
a c
hem
ica
l
sub
sta
nce
whi
ch
has
an
ora
l
L05
0
of
5-5
0
mg/
kg,
a d
erm
al
LD
5Q
of
20
0—
50
0
mg
/k
g,
and
an
aq
ua
ti
c
96
ho
ur
LC
50
of
les
s
th
an
1 m
g/
kg
is
a55
1gn
ed
a
sco
re
of
sev
en,
bas
ed
on
the
ext
rem
e
aqu
ati
c t
oxi
cit
y.
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I(A) Potency:
Criterion:
Weighting Factor
Strong X2
Weak X1
This factor is applied in all categories other than acute toxicity.
Rationale:
Except in the acute toxicity category, the concept of dose to produce a
state
d eff
ect
is ab
sent
in th
e for
egoin
g sc
oring
syste
m.
Howev
er,
it is
.
recognized that materials do vary in their potency and that very potent
substances create greater concern and demand priority consideration over less
potent materials that may evoke the development of similar qualitative effects
but only after much higher does have reached the target cells, organs or
organisms, and often only after longer periods of time.
To account for differences in potency, the rating accorded a substance
under any toxicity categoryis doubled if the material is judged to possess
strong potency.
The distinction between "strong" and "weak" potency with respect to
carcinogens has been maintained for many years. Weak carcinogens are those
which manifest their effects only after repeated dosage over a long period of
time, often at doses which produce other tissue damage or which induce other
eff
ect
s s
uch
as
alt
ere
d m
eta
bol
ic
pro
ces
ses
.
Str
ong
car
cin
oge
ns,
on
the
oth
er
hand, induce neoplasia with much lower doses, sometimes even with a single
exp
osu
re;
lat
ent
per
iod
s m
ay
be
sho
rte
r a
nd
the
car
cin
oge
nic
res
pon
se
is
frequently evoked without other concomitant pathological change.
II. CARCINOGENICITY
Criterion:
Score Category a
4 The chemical has been demonstrated to be a human positive
carcinogen (defined in (a) below) by the oral, dermal or
inhalation route of exposure.
2 The chemical has been demonstrated to be a suspected carcinogen
(defined in (c) below) by the oral, dermal, or inhalation route
of exposure.
1 The chemical has been demonstrated by accepted mutagenicity
screening tests or accepted cell transformation studies to be a
potential carcinogen (defined in (d)).
0 The chemical has been tested by the above systems and has not
been demonstrated to cause cancer or to be a potential
8
 carcinogen.
* Insufficient information available.
Rationale:
Mos
t c
anc
ers
are
bel
iev
ed
to
be
cau
sed
by
exp
osu
re
to
ext
rin
sic
fac
tor
s,
amon
g wh
ich
chem
ical
agen
ts
are
thou
ght
to b
e a
majo
r co
ntri
buto
r.
Thes
e
age
nts
mus
t b
e
ide
nti
fie
d,
eva
lua
ted
,
and
con
tro
lle
d
if
the
inc
ide
nce
of
canc
er i
s to
be r
educ
ed.
The
comm
itte
e re
cogn
izes
the
need
to p
rote
ct t
he
pub
lic
and
the
env
iro
nme
nt
fro
m c
hem
ica
l c
arc
ino
gen
ic
haz
ard
s a
nd
the
ir
effe
cts.
In a
n ef
fort
to m
eet
this
need
, th
e ab
ove
carc
inog
enic
ity
crit
erio
n
was developed.
It
is
ess
ent
ial
tha
t t
he
pro
ced
ure
s u
sed
to
det
erm
ine
a c
hem
ica
l's
carc
inog
enic
ity
pote
ntia
l b
e es
tabl
ishe
d on
the
best
scie
ntif
ic b
asis
as i
s
pra
cti
cal
ly
pos
sib
le.
For
the
pur
pos
e o
f c
las
sif
ica
tio
n,
che
mic
als
will
be
pla
ced
in
cat
ego
rie
s r
ela
tin
g t
o c
arc
ino
gen
ic
eff
ect
s.
If
ins
uff
ici
ent
inf
orm
ati
on
is
ava
ila
ble
to
cla
ssi
fy
a c
hem
ica
l,
it
will
be
so
not
ed.
The
che
mic
al
can
be
rec
las
sif
ied
in
an
app
rop
ria
te
cat
ego
ry
whe
n a
ddi
tio
nal
dat
a
become available.
The
cat
ago
rie
s
of
car
cin
oge
nic
eff
ect
s
are
def
ine
d
as
fol
low
s:
(a) Human Carcinogen
0
Che
mic
al
whi
ch
has
bee
n
dem
ons
tra
ted
by
epi
dem
iol
ogi
cal
and
/or
clinical studies to cause cancer in man.
(b) Positive Animal Carcinogen
0
Ch
em
ic
al
wh
ic
h
ha
s
be
en
fo
un
d
an
d
co
nf
ir
me
d
to
be
ca
rc
in
og
en
ic
in
ani
mal
s.
(If
obs
erv
ati
on
has
bee
n
mad
e
onl
y
in
mic
e,
see
(c)
below.)
(c) Suspected Animal Carcinogen
a
Ch
em
ic
al
wh
ic
h
ha
s
be
en
fo
un
d
to
be
ca
rc
in
og
en
ic
in
on
e
se
ri
es
of
wel
l
de
si
gn
ed
ex
pe
ri
me
nt
s
and
fo
un
d
to
be
no
n-
ca
rc
in
og
en
ic
in
re
pe
at
ed
ex
pe
ri
me
nt
s,
but
no
ex
pl
an
at
io
n
is
ap
pa
re
nt
to
ac
co
un
t
fo
r
th
e
di
sc
re
pa
nc
ie
s
be
tw
ee
n
po
si
ti
ve
and
ne
ga
ti
ve
re
su
lt
s.
0
Ch
em
ic
al
wh
ic
h
ha
s
be
en
fo
un
d
to
be
ca
rc
in
og
en
ic
in
mo
us
e
on
ly
but not confirmed in another species.
(d) Positive in Vitro Test Carcinogen
0
Ch
em
ic
al
wh
ic
h
has
be
en
fo
un
d
by
mu
ta
ge
ni
ci
ty
te
st
s
(wi
th
or
wi
th
ou
t
en
zy
me
ac
ti
va
ti
on
)
to
de
mo
ns
tr
at
e
ca
rc
in
og
en
ic
potential.
 
  
0 Chemical which has been shown to transform normal human or
normal mammalian cells into tumour cells in replicated tests
designed to demonstrate carcinogenic potential.
III. REPRODUCTIVE,
IV. HERITABLE MUTAGENICITY
 
(i.e., teratogenicity and foetal toxicology)
1. teratogenic effects.
2. foetal toxicity.
pathology, behaviour
3. embryotoxicity. .
Criterion:
Score Category
4 Confirmed teratogen
2 Suspect teratogen in multicellular organisms
1 Suspect mutagen in microorganisms
0 Not demonstrated to be a mutagen
* Insufficient information
V. NEUROBEHAVIORAL TOXICOLOGY
Criterion:
Neurotoxicity and the potential of a chemical to cause behavioral changes
in mammals or other animals will be assessed according to the following scores:
Score Category
4 Confirmed human neurotoxic chemical
3 Confirmed animal neurotoxic agent, therefore suspect in humans
1 Suspect animal neurotoxic chemical
0 No neurotoxic activity
* No information
Rationale:
Score Category ,
4 Chemicals known to cause nervous system malfunctions and/or
pathology, behavioral disorders including learning disabilities
in humans, will be considered as confirmed neurotoxic agents for
humans.
3 Chemicals causing neuropathies in experimental animals will be
considered suspect neurotoxic agents for humans.
1 Chemicals shown to cause only behavioral changes in animals will
be considered potentially suspect neurotoxic agents for animals.
10
 0 A chemical, adequately tested for neurobehavioral toxicity with
negative findings will be considered inactive as a neurotoxic
agent.
* Where insufficient information is available testing should be
considered.
Score Category
Confirmed human neurotoxic chemical
Confirmed animal neurotoxic agent, therefore suspect in humans
Suspect animal neurotoxic chemical
No neurotoxic activity
No information
*
O
I
—
‘
w
-
h
VI. CHRONIC ADVERSE EFFECTS
Introduction and Rationale:
The category "Chronic Adverse Effects" contains a large variety of toxic
effects on a variety of target organs and tissue. Some have been left out
because they were considered unlikely to be affected by chemicals in the water
of the Great Lakes. Wherever possiblehowever the systems are included and
scores proposed with occasional examples, which may be deleted.
The wording is usually too short and thus unclear. When effects are
observed they are adverse irreversible effects unless otherwise stated. When
effects are not observed in humans, but only in animals, it does not mean that
the
effe
cts
were
lack
ing
in h
uman
s ex
pose
d to
the
chem
ical
s,
but
rath
er t
hat
humans were not exposed to the chemicals. Human data are obtained from
epidemiological studies and not from clinical reports only, which may be
erroneous in the association proposed.
When no adverse effects are observed it means that no serious adverse
effects are found. Weight loss can always be produced with a high enough dose
with any choice of chemical, but that is not meant here.
No attention was paid to genetic weakness of human populations, although
the means to do so exist. However, in experiments on animals it has
frequently been the custom to choose a strain that would display genetic
susc
epti
bili
ties
in o
rder
to e
xagg
erat
e th
e ef
fect
.
Alth
ough
this
is
permissible it should be recognized as such and given a particular
reco
gnit
ion,
sinc
e ex
trap
olat
ion
to t
he n
orma
l hu
man
popu
lati
on w
ould
be
impossible or difficult.
Criterion:
(a) Sense Organs
Score Category
N.B. Unless specified the effects are irreversible and/or
progressive
Effects observed in humans (e.g., cataracts)
Effects not observed in humans, but on experiments in animals
N
O
)
11
 
  
1 Reversible effects observed in humans or animals
0 No adverse effects observed
* No information
Some
effe
cts
of c
hemi
cals
may
be c
ause
d by
inte
rfer
ence
with
nerv
e
func
tion
or t
oxic
ity
to t
he n
erve
itse
lf a
nd w
ill
be cl
assi
fied
unde
r ca
tego
ry
V.
(b) Hepatobiliary System
Score Category
3
Eff
ect
s o
bse
rve
d i
n h
uma
ns
(e.
g,
cir
rho
sis
,
bil
edu
ct
hyperplasia) ’
2 Effects not observed in humans, but in animal experiments
1 Reversible effects observed in humans or animals (e.g.,
bilirubinemia)
0 No adverse effects observed
* No information
Reversible effects should be distinguished from effects which may also be
reve
rsib
le b
ecau
se,
afte
r th
e ne
crot
ic e
piso
de i
s ov
er,
rege
nera
tion
can
replace the lost tissue.
(c) Urinary System
Score Category
3 Effects in humans
2 Effects not observed in humans, but in animal experiments
1 Reversible effects in humans or animals
0 No effects observed
*
No information
It is suggested including in these categories adverse effects observed, as for
instance, with NTA which produced tubular damage to the kidney at relatively
low
leve
ls a
nd w
hich
prod
uced
rena
l ca
ncer
s at
very
high
dose
leve
ls w
hich
would also be reported of course under category II.
(d) Cardio—vascular system
Score Category
3
Effec
ts o
bserv
ed in
human
s
1
2 Effects not observed in humans, but in animal experiments
1 Reversible effects observed in humans or animals
0 No effects observed ,
* No information
A weighting factor of 2x is proposed for the adverse effects of this
chemical if the impaired health (due to other causes) will considerably
aggravate the toxicity of the chemical. The same consideration applies to the
respiratory system and the lymphatic system.
12
 (e) Respiratory System
Score Category
3 Effects observed in humans
2
Eff
ect
s n
ot
obs
erv
ed
in
hum
ans
, b
ut
in
ani
mal
s i
n e
xpe
rim
ent
s
1
Rev
ers
ibl
e e
ffe
cts
obs
erv
ed
in
hum
ans
or
ani
mal
s
0 No effects observed
* No information
A w
eig
hti
ng
fac
tor
of
2x
is
pro
pos
ed
her
e a
lso
eve
n t
hou
gh
the
con
tri
but
ion
of
che
mic
als
via
the
Gre
at
Lak
es
to
the
res
pir
ato
ry
sys
tem
may
be
rar
e o
r u
nli
kel
y.
The
con
dit
ion
s o
f i
mpa
ire
d h
eal
th
may
inc
lud
e e
mph
yse
ma,
edema, fibrosis, etc.
(f) Blood Forming System
Score Category
3 Effects in humans, e.g., porphyrias
2
Eff
ect
s n
ot
obs
erv
ed
in
huma
ns,
but
in‘
ani
mal
exp
eri
men
ts
1
Rev
ers
ibl
e
eff
ect
s
in
hum
ans
or
ani
mal
s
0 No effects observed
* No information
(9) Lymphatic System
Sc
or
e
Ca
te
go
ry
3
Eff
ect
s
in
hum
ans
,
e.g
.,
imm
uno
pat
hol
ogy
2
Ef
fe
ct
s
no
t
ob
se
rv
ed
in
hu
ma
ns
,
but
in
an
im
al
ex
pe
ri
me
nt
s
1
Rev
ers
ibl
e
eff
ect
s
in
hum
ans
or
ani
mal
s
inc
lud
ing
chr
omo
som
al
abnormalities
0 No effects observed
* No information
(h) Endocrine System
Sc
or
e
Ca
te
go
ry
3 Effects in humans
2
Ef
fe
ct
s
no
t
ob
se
rv
ed
in
hu
ma
ns
bu
t i
n
ex
pe
ri
me
nt
al
an
im
al
s
1
Re
ve
rs
ib
le
ef
fe
ct
s
in
hu
ma
ns
or
an
im
al
s
0 No effects observed
* No information
Th
is
su
bc
at
eg
or
y
sh
ou
ld
in
cl
ud
e
ad
ve
rs
ee
ff
ec
ts
on
th
e
hy
po
th
al
am
us
an
d
th
e
pi
tu
it
ar
y
gl
an
d
as
we
ll
as
th
e
en
do
cr
in
e
or
ga
ns
un
de
r
pi
tu
it
ar
y
co
nt
ro
l
an
d
ta
rg
et
or
ga
ns
un
de
r
th
e
in
fl
ue
nc
e
of
sp
ec
if
ic
ho
rm
on
es
.
Th
e
su
bc
at
eg
or
y
ma
y
al
so
ha
ve
to
co
nt
ai
n
th
e
ef
fe
ct
s
of
ch
em
ic
al
s
se
cr
et
ed
by
th
e
ma
mm
ar
y
gl
an
d
an
d
af
fe
ct
in
g
th
e
yo
un
g
of
fs
pr
in
g.
(i) Reproductive System
Sc
or
e
Ca
te
go
ry
3
Ef
fe
ct
s
in
hu
ma
ns
,
e.
g.
,
st
er
il
it
y
2
Ef
fe
ct
s
no
t
ob
se
rv
ed
in
hu
ma
ns
bu
t
in
ex
pe
ri
me
nt
al
an
im
al
s
1
Re
ve
rs
ib
le
ef
fe
ct
s
ob
se
rv
ed
in
hu
ma
ns
or
an
im
al
s
13
 
 0 No effect observed
* No information
Thi
s c
ate
gor
y m
ay
also
con
tai
n t
he
eff
ect
s o
f c
hem
ica
ls
bin
din
g t
o
enc
eph
ali
n-r
ece
pto
rs,
e.g
.,
pot
ent
ial
los
s o
f l
ibi
do
(j) Gastro-Intestional System
Score Category
3 Effects observed in humans
2
Eff
ect
s n
ot
obs
erv
ed
in
hum
ans
, b
ut
exp
eri
men
tal
ani
mal
s
1 Reversible effects in humans or animals
0 No effects observed ‘
*
No
inf
orm
ati
on
I
A we
ight
ing
fact
or o
f 2x
may
have
to b
e ap
plie
d in
this
subc
ateg
ory
beca
use
impa
irme
nt o
f no
rmal
func
tion
may
lead
to a
ggra
vate
d re
spon
ses
to
chemicals entering the 6.1. tract.
(k) Skin
Score Category
2 Effects observed in humans
1
Eff
ect
s o
bse
rve
d i
n a
nim
als
whi
ch
may
be
rev
ers
ibl
e o
r
irreversible
0 No effects observed
* No information
A we
ight
ing
fact
or o
f 2x
may
be a
ppli
cabl
e un
der
cond
itio
ns o
f im
pair
ment
producing abnormal absorption of chemicals or aggravation of effect.
The committee is currently evaluating the 400 compounds identified in the
Water Quality Board's report (193. gig) utilizing the above categories of
criteria and scoring systems.
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 ESTIMATES OF HUMAN EXPOSURE
FROM ENVIRONMENTAL DATA
Possible health effects of Great Lakes water quality from any chemical
compound or agent are a function of both the toxic (carcinogenic) properties
of the compound and the possible exposure of man to it.
In order to be concerned about a compound, we consider exposure of any
identifiable group of people, however small, and in any area in the Great
Lakes Basin, however limited in size.
Exposure is determined by:
1. Inputs into the Great Lakes and the resulting concentrations in the
several compartments of the Great Lakes ecosystem.
2. Rates of transformation and translocation within'and between compartments.
3. Intake by man of water or food from these compartments.
Beginning with point (3) we identify the following target populations:
(a) Any local population deriving their drinking water from the Great
Lakes.
(b) Any local population deriving a substantial portion of their total
food intake from Great Lakes fish.
(c) Any local population consuming waterfowl (hunters and their families).
(d) Any local population deriving a significant portion of their food
from land irrigated with Great Lakes water or from livestock drinking
Great Lakes water.
The following additional target populations are recognized as part of the
greater ecosystem of the Great Lakes but are excluded from considerations of
Great Lakes water quality.
(e) Local populations deriving food from land receiving wastewater
sludges.
(f) Populations exposed in the occupational, domestic, and urban
environment to contaminants identified in Great Lakes water and
traceable to land sources.
Exposures from (e) to (f) must be taken into account also in determining
total exposure of a local population to the contaminant.
Input and concentration data are the points of departure for estimates of
exposure. They are shown in boxes in Figure 1, below. Input data are
15
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available from measurements of concentrations and flows, or from estimates of
production, use, and loss of chemicals. Input data are related to
concentration data by factors such as dilution, partition, chemical or
microbial degradation, bioaccumulation, etc., (marked by arrows in Figure 1).
For some compounds, the data base available involves numerous measurements
of the compounds in several compartments over a large part of the Great Lakes
Basin. For other compounds, data are sparse and are available only for
limited areas and few, or one compartment of the ecosystem. For the areas
known to show measurable concentrations of the compounds, order-of-magnitude
estimates of concentrations in other compartments in the same area can be made
by applying conversion factors on dilution, partition, degradation, and
bioaccumulation. Extrapolation to other areas in the basin is difficult and
would be based on known patterns of production and use of chemicals,
generalizations on likely sources, etc. In order to undertake this effort,
the group recommends the reworking of the available data base (Great Lakes
Water Quality Board - Appendix E, Status Report on Organic and Heavy Metal
Contaminants in the Lakes Erie, Michigan, Huron and Superior Basins, IJC,
Windsor, Ontario, July 1978) into a more useful format giving for each
compound, the available data by geographic location and by compartment (amount
discharged or effluent concentration measured, concentration in sludge,
concentration in water, concentration in sediment, concentration in fish,
concentration in other biota). This information will then be analyzed by the
above procedures to derive estimates of exposure for any of the possible
target populations.
This estimate of the exposure together with data on toxicity, including
factors such as carcinogenicity, persistence in man, etc., for each compound
will produce a measure of concern by the committee for public health effects
from any given compound, refined as is possible by estimates of synergistic
and other interactions among compounds. If effect levels are known for a
compound, the ratio of exposure level to effect level is a measurement of the
public health concern.
17
  
 The IogicaI sequence of this procedure is sumnarized in Figure 2, beIow.
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SU
RE
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Fig. 2
In m
any
case
s t
he
avai
IabI
e d
ata
M“
not
perm
it
a d
ecis
ion
on
poss
ibIe
healt
h co
ncern
with
suffi
cient
certa
inty,
and
a caI
I fo
r ad
ditio
naI
data
may
resuIt.
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 INTERACTIONS IN TOXICOLOGY:
AN OVERVIEW
Interactions in drugs as suggested in the translation of the Papyrus Ebers
is an ancient interest (Rossi, '63). The course of history of interactions in
toxicology would run parallel to that for drugs since no drug is free of toxic
effects (Fingl and Woodbury, '70). Accumulated knowledge of drug
interactions, however, is much greater than interactions in toxicology (James,
£5 31., '78). This latter statement would be expected when one considers the
age difference between these two sciences. Man, not necessarily man the
scientist, has been interested for centuries in the basic effect of a poison.
How it worked, or interacted, was not his concern as long as the measured
effect, death, was achieved. From that simple observation of yesterday,
scientists today are turning more earnestly to the “question of interaction of
the causes" (Rothman, '76).
Interactions in toxicology are no longer viewed as a basic biochemical
event but they are recognized as complex, complicated and controversial.
Assessment of a toxicant is interrelated to nutrition, stress, age, sex,
genetics, prior or concurrent diseases, body weight, route of administration,
its pharmacokinetics and the environment. With so many diverse factors
affecting the observed effect the underlying mechanism becomes very difficult
to solve or understand (i.e., complicated). Controversies will undoubtedly
arise because most interactions in toxicology have not been resolved.
Foremost among these controversies are the problems of interactions with
minute or large dosages of a chemical carcinogen (Maugh, '78). The task of
this overview is to look at interactions in toxicology, excluding drug
toxicology. Drug toxicology cannot be completely forgotten because many of
the terms and ideas of interactions in pharmacology have entered toxicology.
This presentation contains a brief outline of interactions; its definition,
types and controversies. The basic intention is that of an outline. Models
and approaches to assessing interactions in toxicology are also present.
Definition
The word interaction is too often used in a facile manner to confer an
understanding of a sequence of biochemical events for which little or nothing
is known. It is used to bridge the veiled gap between (i.e., inter-) cause
and effect. An illusion is presented, analogous to the use of the word
evolution, that the measured effect can be attributed to an interaction. Yet,
no explanation is given to or is known of the series of biochemical events
which comprise the interaction. The truth in most instances is that we do not
know, as yet, the mechanisms of interactions. A discussion of interactions,
more often than not, describes the measured effect with little reference to
the causal mechanism.
Death is the easiest measured effect of an interaction. To gain an
appreciation of the potency (i.e., toxicity) with which the interaction has
ensu
ed,
toxi
colo
gist
s ha
ve d
evis
ed t
he L
050.
The
meas
urem
ent
of t
he
dose—response relationship can be derived for a given toxicant by several
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 mod
els
,
for
ins
tan
ce,
the
met
hod
of
Mil
ler
and
Tai
nte
r
('4
4),
Lit
chf
iel
d
and
Wil
cox
on
('4
9),
and
Nei
l
('5
2).
A s
tan
dar
d p
rot
oco
l
for
der
ivi
ng
the
LD5
0
was
est
abl
ish
ed
as
a f
urt
her
ass
ura
nce
tha
t t
he
est
ima
ted
val
ue
of
a t
ox1
can
t
can
be o
btai
ned
in a
ll
labo
rato
ries
(Fed
. Re
g.).
Chan
ges
in t
he L
050
are
used as an interaction indicator (Magos, '74).
Tes
ts
in
tox
ico
log
y,
suc
h a
s a
cut
e,
chr
oni
c,
rep
rod
uct
ive
and
ter
ato
log
ica
l,
pro
vid
e a
dir
ect
mea
sur
eme
nt
of
the
eff
ect
of
the
int
era
cti
on
but
not
hin
g
is
con
tri
but
ed
tow
ard
s t
he
mec
han
ism
of
the
int
era
cti
on,
p§r
_§g
.
The
gre
ate
st
con
tri
but
ion
tow
ard
s u
nde
rst
and
ing
int
era
cti
ons
has
com
e w
ith
the
app
lic
ati
on
of
kin
eti
cs
to
a t
oxi
can
t.
Pri
nci
pal
ly
dev
elo
ped
for
use
in
cli
nic
al
eva
lua
tio
n a
nd
use
of
dru
gs
(Le
vy
and
Gib
ald
i,
'75)
, t
he
sci
enc
e o
f
pha
rma
cok
ine
tic
s i
s p
rov
idi
ng
a m
uch
nee
ded
sti
mul
us
in
tox
ico
log
y (
Geh
rin
g,
et a
l.
'76)
.
Info
rmat
ion
on t
he a
bsor
ptio
n,
dist
ribu
tion
, me
tabo
lism
and
exc
ret
ion
of
a c
hem
ica
l
is
der
ive
d b
y a
tim
e p
lot
of
the
dat
a w
hic
h
is
the
n
applied to compartmental open models.
Res
ult
s f
rom
the
bat
ter
y o
f t
oxi
col
ogi
cal
tes
ts
and
pha
rma
cok
ine
tic
s a
re
obt
ain
ed
und
er
con
tro
lle
d e
xpe
rim
ent
al
con
dit
ion
s i
n w
hic
h a
ll
pos
sib
le
par
ame
ter
s (
i.e.
, t
emp
era
tur
e,
hum
idi
ty,
str
ess
, d
ose,
nut
rit
ion
, e
tc.
) a
re
reg
ula
ted
.
The
des
ire
is
und
ers
tan
dab
le
bec
aus
e w
ith
out
eli
min
ati
ng
or
con
tro
lli
ng
the
man
y v
ari
abl
es,
agr
eem
ent
on
the
act
ion
of
a t
oxi
can
t w
oul
d
nev
er
be
ach
iev
ed.
How
eve
r,
inf
orm
ati
on
der
ive
d w
ith
max
imu
m c
ont
rol
is
not
the
real
life
situ
atio
n fo
r,
in r
eali
ty,
the
cont
rols
are
redu
ced
and
the
tox
ica
nts
bec
ome
mul
tip
les
.
Int
era
cti
ons
, e
spe
cia
lly
int
era
cti
ons
of
tox
ica
nts
in
com
bin
ati
on,
mus
t b
e c
ons
ide
red
in
the
ir
com
ple
xit
y (
Mago
s,
'76)
.
Finn
ey
('52
) pr
esen
ted
math
emat
ical
mode
ls t
o ex
plai
n th
e po
ssib
le
dif
fer
ent
eff
ect
s o
bta
ine
d f
or
joi
nt
int
era
cti
ons
of
bio
log
ica
lly
act
ive
che
mic
als
.
The
use
ful
nes
s o
f F
inn
ey'
s m
ode
l w
as
tes
ted
by
Smy
th,
et
al.
('69
and
'70)
.
Pha
rma
col
ogy
has
use
d t
he
Loe
we,
('53
) a
nd
the
app
roa
ch
of_
Che
n a
nd
Ens
or
('53
and
'54)
to
ana
lys
e e
ffe
cts
of
com
bin
ed
dru
g i
nte
rac
tio
ns.
Bot
h o
f
the
se
sci
enc
es,
tox
ico
log
y a
nd
pha
rma
col
ogy
, u
se
the
sam
e t
erm
s t
o d
esc
rib
e
inte
ract
ions
and
unfo
rtun
atel
y ha
ve c
arri
ed o
n so
me d
isag
reem
ent
abou
t th
e
mea
nin
g o
f t
he
ter
ms
" s
yne
rgi
sm"
, "
pot
ent
iat
ion
",
"se
nsi
tiz
ati
on"
but
wit
h
more
agre
emen
t on
the
term
s ad
diti
ve,
anta
goni
stic
and
inde
pend
ent.
Types of Interactions
 
The confusion surrounding synergism to describe an effect of an
inte
ract
ion
is a
noth
er e
xamp
le a
risi
ng f
rom
a la
ck o
f un
ders
tand
ing
of t
he
mech
anic
s of
inte
ract
ions
.
Some
auth
ors
use
"the
end-
effe
ct o
f th
e
comb
inat
ion
as a
meas
ure
of c
ompa
riso
n wh
ile
othe
rs u
sed
the
indi
vidu
al
activities of the compounds" (Veldstra, '56). Others adhere to the
epistemological meaning.
Synergism (GK. synergos) literary means “working together", "cooperation"
(Ros
si,
'63
and
Suni
er,
'72)
.
Syne
rgis
m in
toxi
colo
gy i
s ge
nera
lly
acce
pted
as being similar to that definition used in pharmacology; "the cooperative
action of discrete agents, such that the total effect is greater than the sum
of t
he t
wo e
ffec
ts t
aken
inde
pend
entl
y"
(Vel
dstr
a,
'56)
and
that
adop
ted
for
epidemiology where “the risk attributable to a combined exposure exceeds the
sum
of t
he r
isks
attr
ibut
able
to e
ach
expo
sure
sepa
rate
ly"
(Rot
hman
, '
74).
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 Magos ('74), however, considers that when "the action can be greater than the
algebraic summation" it is supplemental synergism or potentiation. He also
uses the term "additive synergism" as the simple algebraic sum. Veldstra
('56) argues against the use of the term potentiation.
Interactions which produce synergistic effects are not an exception but a
common occurrence. Some food additives have a synergistic toxic effect when
incorporated in a purified, low fiber, diet (Ershoff, '76). Herbicides can
increase the toxicity of insecticides to potencies greater than either given
alone (Lichtenstein, e: 31. '73). Methylmercury in combination with nitrite
and ethylurea reduced survival of progeny (Nixon, '77). Combinations of
aflatoxin B, and Fusarium toxic, T—Z, produced a synergistic lethal response
(Lindenfelser, gt g1. '74). The herbicide silvex is degraded by the
synergistic action of aquatic microorganisms (Ou and Sikka, '77). Hicks and
Chowaniec ('77) studied the importance of synergy between weak carcinogens and
bladder tumours.
Veldstra ('56) states that the term "potentiate" should be discontinued
because it means "to endow with power" and in combination the resident
"power," viz. specific activity, is not altered but "the effectiveness of the
power already present is enhanced." Fingl and Woodbury ('70) agree with
Veldstra that potentiation should be abandoned. Rossi ('63) notes that
Webster's dictionary provides some justification for its use; potentiate - "to
make potent or more effective." Scientists may be using "potentiate" in the
same sense that it is employed in physics, that is, energy which is involved
because of position or condition. Magos ('74) defines potentiation, also
called supplemental synergism, as an action greater than the algebraic
summation. The latter definition is the same as that given to synergism.
Enhancement of a response by a combination of an active and an inactive
com
pou
nd
has
als
o
bee
n
des
ign
ate
d
as
sen
sit
iza
tio
n
(Ro
ssi
,
'63
).
Fin
all
y,
the
re
is
the
oft
en
cit
ed
"sy
ner
gis
tic
" i
nte
rac
tio
n o
f E
PN
and
mal
ath
ion
alt
hou
gh
the
aut
hor
s r
efe
rre
d t
o t
his
int
era
cti
on
as
a "
pot
ent
iat
ion
"
(Frawley, gt_al. '57).
Alt
hou
gh
the
re
is
som
e c
onf
usi
on
abo
ut
the
mea
nin
g o
r u
se
of
pot
ent
iat
ion
,
thi
s h
as
not
imp
ede
d t
he
pub
lic
ati
on
of
pap
ers
.
Iso
pro
pyl
alc
oho
l a
nd
ace
ton
e
pot
ent
iat
ed
the
hep
ato
tox
ici
ty
in
rat
s o
f c
hlo
rin
ate
d h
ydr
oca
rbo
ns
(Tr
aig
er
and
Plaa
, '
74).
The
chl
ori
nat
ed
hyd
roc
arb
on,
car
bon
tet
rac
hlo
rid
e w
as
pot
ent
iat
ed
in
rat
s b
y s
odi
um
nit
rit
e (
Sua
rex
and
Bho
nsl
e,
'74
).
Lea
d
chl
ori
de
and
lea
d n
itr
ate
inc
rea
sed
mor
tal
ity
in
mic
e b
y e
nha
nce
men
t o
f
enc
eph
ali
tog
eni
c p
ote
nti
al
of
Lan
gat
vir
us
(Th
ind
& S
ing
h,
'77
).
Mur
phy
rep
ort
ed
the
pot
ent
iat
ion
of
tox
ici
ty
of
the
ane
sth
eti
c f
lur
oxe
ne
by
polychlorinated biphenyls.
Ant
ago
nis
tic
int
era
cti
ons
whi
ch
eli
min
ate
an
und
esi
rab
le
eff
ect
are
the
mos
t b
ene
fic
ial
to
man
.
Thi
s h
app
ens
whe
n t
he
com
bin
ed
eff
ect
s a
re
les
s t
han
tha
t o
f t
he
act
ive
com
pon
ent
alo
ne.
An
ant
ago
nis
tic
eff
ect
is
rep
ort
ed
for
rib
ofl
avi
n a
nd
hep
ato
ma
ind
uct
ion
by
an
azo
dye
(La
mbo
oy,
'76)
.
Rat
s
pre
tre
ate
d w
ith
ald
rin
are
pro
tec
ted
aga
ins
t t
he
tox
ici
ty
of
par
ath
ion
(Ki
nos
hit
a,
'74
).
Sel
eni
um
pro
tec
ts
aga
ins
t
cad
miu
m
and
mer
cur
y
tox
ici
ty
(Parizek, '76).
The
re
is
no
sho
rta
ge
of
mod
els
(i.
e.,
pro
ced
ure
s t
o b
e f
oll
owe
d o
r
emu
lat
ed)
to
det
erm
ine
the
eff
ect
s o
f t
he
var
iou
s
int
era
cti
ons
,
how
eve
r,
the
re
21
 
  
are
few
mod
els
tha
t e
xpl
ain
the
int
era
cti
ons
.
The
mod
els
for
der
ivi
ng
the
L05
0 a
nd
tho
se
of
pha
rma
cok
ine
tic
s h
ave
bee
n d
isc
uss
ed.
Run
ner
('6
7)
presented models to explain the various effects (e.g., synergistic,
ant
ago
nis
tic
) f
or
con
com
ita
nt
ter
ato
gen
ic
tre
atm
ent
.
Pro
ble
ms
of
syn
erg
ism
and
anta
goni
sm i
n ep
idem
iolo
gy a
re d
iscu
ssed
by R
othm
an
('74
and
'76)
.
Last
and
Cro
ss
('78
) p
res
ent
ed
a mo
del
for
ass
ess
ing
bio
log
ica
l e
ffe
cts
of
atmo
sphe
ric
poll
utan
ts
on t
he r
espi
rato
ry t
ract
, mu
cus-
prod
ucin
g a
ppar
atus
.
A
met
hod
was
pro
pos
ed
by
Car
lso
n a
nd
Baz
zaz
('77
) t
o q
uan
tit
ate
the
con
cep
t o
f
syne
rgis
m in
plan
ts.
A mo
del
to t
est
the
effe
ct o
f ex
posu
re t
o a
subt
oxic
chal
leng
e up
on c
ellu
lar
inte
grit
y is
desc
ribe
d by
Chin
, gt
_al.
('78
).
A
bioassay was reported for detecting both synergistis and antagonists of
paraoxon and malaoxon (Cohen and Murphy, '73).
Controversies
Undoubtedly, the most controversial subject of interactions is in chemical
carc
inog
ens.
The
argu
ment
s i
ndic
ate
how
litt
le
is k
nown
abou
t in
tera
ctio
ns
at
very
low
dosa
ges
(Mau
gh,
'78)
. T
here
pres
entl
y ex
ist
two
scho
ols
of t
houg
ht;
"one hit" hypothesis or single event and "threshold" hypothesis, or no-effect
leve
l.
The
for
mer
bel
iev
e b
asi
cal
ly
tha
t c
anc
er
res
ult
s f
rom
the
int
era
cti
ons
of one molecule of a carcinogen with a critical receptor in one cell. Models
suc
h a
s t
he
pro
bit
and
Man
tel
-Br
yan
ext
rap
ola
tio
ns
are
use
d i
n t
his
case
.
The
othe
r sc
hool
stat
es t
hat
ther
e is
a no
-eff
ect
dose
for
a ch
emic
al c
arci
noge
n
gov
ern
ed
by
a s
eri
es
of
pha
rma
cok
ine
tic
int
era
cti
ons
bef
ore
rea
cti
ng
wit
h
DNA. Gehring ('76) has demonstrated that the pharmacokinetics do change with
different doses of a carcinogen. v
Toxi
colo
gica
l t
ests
also
devi
ate
towa
rd
"lar
ger
than
life
" do
sage
s an
d in
so doing create a controversy over the use of super dosages. One side argues
tha
t w
e m
ust
obt
ain
as
muc
h k
now
led
ge
as
pos
sib
le
abo
ut
the
und
esi
rab
le
eff
ect
s o
f a
tox
ica
nt.
The
oth
er
sid
e s
tat
es
tha
t t
hes
e a
re
zea
lou
s
pla
tit
ude
s
whi
ch
are
not
the
rea
l
lif
e
sit
uat
ion
s
and
the
acq
uir
ed
kno
wle
dge
is often misused.
Int
era
cti
ons
in
ter
ato
log
y a
nd
mut
age
nic
ity
tes
ts
are
not
wit
hou
t t
hei
r
con
tro
ver
sie
s.
Do
the
sam
e i
nte
rac
tio
ns
whi
ch
cul
imi
nat
e i
n b
irt
h d
efe
cts
in
pol
yto
cou
s
ani
mal
s e
xis
t i
n m
an?
Wer
e n
ot
the
dos
es
giv
en
abs
urd
?
The
emp
has
is,
tod
ay,
is
tha
t a
che
mic
al
is,
"te
rat
oge
nic
in
the
[at
. . .
. . .
or
the
mou
se
. . .
. . .
or
the
rab
bit
",
cle
arl
y i
ndi
cat
ing
tha
t i
t h
as
not
bee
n
dem
ons
tra
ted
so
in m
an.
Sim
ila
rly
, t
he
pro
ble
m o
f e
xtr
apo
lat
ing
the
res
ult
s
of mutagenicity tests to a multicellular organism.
 
Conclusions
It i
s in
here
nt t
hat
the
use
of "
over
view
" i
n th
e ti
tle
of t
his
pape
r wi
ll
resu
lt i
n ot
her
aspe
cts
of i
nter
acti
ons
bein
g ov
ervi
ewed
.
The
most
evid
ent
is
a citation of mechanisms of interaction that are known.
Dubois, et al. ('68) provided the explanation for the synergistic effect
between EPN and Malathion. This original observation had led to an
unde
rsta
ndin
g of
the
bioc
hemi
cal
mode
of a
ctio
n of
pest
icid
es (
Corb
ett
'74
and
Wilk
inso
n,
'71
and
'76)
.
Some
insi
ght
into
the
mech
anis
m of
carc
inog
enes
is
has been achieved. It is now thought to be a two-stage event which requires,
firs
tly,
an i
niti
ator
and
then
a pr
omot
er (
Mill
er,
'78)
. C
onne
y an
d Bu
rns,
22
 ('72) reported other possible mechanisms of interaction for insecticides.
Mechanisms of interaction, briefly presented in the preceding paragraph,
have not completely eluded research, however; they are complex, complicated
and controversial.
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 photomirex is 10—100 times more toxic than mirex and 5 times more toxic than
kepone. In rat feeding studies, photomirex was observed to produce lesions in
the testes, thyroid and liver of male rats. Subsequent experiments have shown
that this compound causes ultrastructural alterations in the liver and testes
at extremely low levels, and that the alterations persist for up to a year
after photomirex exposure has ceased. Like its parent compound mirex,
photomirex is also able to produce cataracts in suckling rats whose mothers
are exposed to the compound. Metabolism and pharmacokinetic data have shown
that photomirex is not metabolized in rats to any significant degree, and is
not excreted in the bile. The main excretory route is through the feces.
Conclusions
The data presented at the meeting on photomirex indicate that this compound
could have greater potential as a human health hazard than mirex. This
example serves to indicate that Great Lakes Monitoring and Surveillance
Programs should be designed not only to provide data on parent compounds, but
also on their degradation products.
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LEAD
In its Final Report, PLUARG drew attention to its concern over the build
up of lead in sediments, particularly in Lakes Erie and Ontario. Studies
undertaken by PLUARG suggest that non-point sources are by far the greatest
component of the load.
Concern over lead at this time arises not from any evidence that current
levels of lead in drinking water or fish tissues exceed health-based
regulatory standards, but because of recent evidence that inorganic lead in
sediments may be transformed into more toxic organic forms by biological
mechanisms in Great Lakes sediments.
The major diffuse source of lead in the Great Lakes Basin is the
automobile. Alkyl lead compounds have been extensively used to improve the
combustion characteristics of gasoline. When burned in the gasoline engine,
most lead in gasoline is converted into inorganic form and emitted as halides
which subsequently are converted during aging to oxides, sulphates and
carbonates. In these compounds, lead is in particulate form and settles over
the landscape as dust. Lead from automobile exhausts enters the aquatic
system primarily in surface run-off although a small proportion undoubtedly
28
 
 enters the lakes through atmospheric fallout and precipitation.
In 1975-76, three different groups of scientists (including one from the
Canada Centre for Inland Waters, the others being in the United Kingdom and in
Germany) reported that micro-organisms can methylate organic and inorganic
lead compoundsl-3. By analogy with mercury, the Comnittee had concern that
the existence of methylated lead in the environment could lead to the
recognition of hitherto unsuspected toxic effects.
The Committee reviewed the evidence relating to biomethylation of lead in
the aqueous environment. It noted a recent report of the World Health
Organization's Task Group on Environmental Health Criteria for Lead which
concludes that:
"Acute toxicity results in an encephalopathy that differs
greatly from the effects of inorganic lead on the central
nervous system. Some components of the toxic effect are
probably due to the alkyl compound as a whole rather than
its lead components.“
The Comnittee concluded that the substrates, conditions and mechanisms
which may lead to alkylation of lead in the environment are not known at the
present time, and it recognizes the need for improvements in analytical
methods and quality control procedures. Nevertheless, it considers that there
is a need for exploratory measurements to be made to determine whether
alkylated lead compounds are present in sediments, algae, invertebrates, fish
and wildlife from the Great Lakes, and, if so, in what form and in what
concentration. The Committee is willing to evaluate such data with a view to
elu
cid
ati
ng
the
pos
sib
le
hea
lth
eff
ect
s i
n o
rde
r t
o d
ete
rmi
ne
whe
the
r p
res
ent
tol
era
nce
s f
or
lead
; e
spe
cia
lly
in
fish
, n
eed
re-
eva
lua
tio
n.
The
Com
mit
tee
req
ues
ts
the
Wat
er
Qua
lit
y B
oar
d a
nd
the
Res
ear
ch
Adv
iso
ry
Boa
rd
to
enc
our
age
the
gat
her
ing
and
pub
lic
ati
on
of
such
dat
a i
n c
onj
unc
tio
n w
ith
on-
goi
ng
mon
ito
rin
g e
ffo
rts
and
to
bri
ng
eme
rgi
ng
inf
orm
ati
on
and
ana
lyt
ica
l d
ata
to
its attention.
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 @RECOMMENDATIONS
During 1978, the committee proposed to both Boards, the following
activities for inclusion in the IJC Regional Office program budget.
1.
A Study on Intervention Guidelines for Great Lakes Environmental
Contaminants in Fish
A survey would be made of the appropriate regulatory agencies in the
Great Lakes Basin to determine and document the philosophy underlying
the rationale used in setting standards for individual environmental
contaminants in fish.
The assignment would be contracted to an individual familiar with the
regulatory agencies concerned and with their appropriate
representatives, at all levels of government affecting the Great
Lakes. Hence, a period of extensive travelling would be anticipated
by the consultant.
The study would aid in clarifying cases of diSparity among different
agencies by delineating and comparing the criteria used in deriving
their standards.
Est
ima
ted
cos
t o
f t
his
stu
dy
- $
10,
000
(FY
79/
80)
.
A Wo
rksh
op o
n th
e In
tera
ctio
n of
Toxi
c Ch
emic
als
of C
once
rn i
n th
e
Great Lakes Ecosystem — $15,000 (FY 80/81)
Mod
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osu
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and
ver
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is
nec
ess
ary
for
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dic
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g
the
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bin
ed
eff
ect
s o
f t
he
com
pou
nds
pre
sen
t.
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ed
on
acu
te
tox
ici
ty
dat
a
for
the
ind
ivi
dua
l
che
mic
als
,
pre
dic
tio
n o
f t
hei
r
joi
nt
act
ion
has
bee
n
pos
sib
le
but
is
pre
sen
tly
lim
ite
d
to
han
dli
ng
two
or
thr
ee
int
era
cti
ng
com
pou
nds
at
one
tim
e.
The
wor
ksh
op
is
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end
ed
to
rev
iew
the
cur
ren
t s
tat
e o
f k
now
led
ge
co
nc
er
ni
ng
th
es
e
pr
ed
ic
ti
ve
mo
de
ls
,
th
e
na
tu
re
of
th
ei
r
da
ta
req
uir
eme
nts
,
and
the
lim
ita
tio
ns
of
the
ir
app
lic
ati
on.
In
add
iti
on,
the
res
ult
s
of
thi
s
act
ivi
ty
wil
l
com
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men
t
the
Wat
er
Qua
lit
y
Boa
rd'
s
lis
t
of
che
mic
als
fou
nd
in
the
Gre
at
Lak
e
eco
sys
tem
and
wil
l
aid
in
th
e
pr
oc
es
s
of
id
en
ti
fy
in
g
and
qu
an
ti
fy
in
g
po
te
nt
ia
l
toxicological effects of interactions.
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